Castor oil induces laxation and uterus contraction via ricinoleic acid activating prostaglandin EP3 receptors

Castor oil is one of the oldest drugs. When given orally, it has a laxative effect and induces labor in pregnant females. The effects of castor oil are mediated by ricinoleic acid, a hydroxylated fatty acid released from castor oil by intestinal lipases. Despite the wide-spread use of castor oil in conventional and folk medicine, the molecular mechanism by which ricinoleic acid acts remains unknown. Here we show that the EP3 prostanoid receptor is specifically activated by ricinoleic acid and that it mediates the pharmacological effects of castor oil. In mice lacking EP3 receptors, the laxative effect and the uterus contraction induced via ricinoleic acid are absent. Although a conditional deletion of the EP3 receptor gene in intestinal epithelial cells did not affect castor oil-induced diarrhea, mice lacking EP3 receptors only in smooth-muscle cells were unresponsive to this drug. Thus, the castor oil metabolite ricinoleic acid activates intestinal and uterine smooth-muscle cells via EP3 prostanoid receptors. These findings identify the cellular and molecular mechanism underlying the pharmacological effects of castor oil and indicate a role of the EP3 receptor as a target to induce laxative effects.

[1]  Stefan Offermanns,et al.  G12-G13–LARG–mediated signaling in vascular smooth muscle is required for salt-induced hypertension , 2008, Nature Medicine.

[2]  S. Phillips,et al.  Inhibition of ileal water absorption by intraluminal fatty acids. Influence of chain length, hydroxylation, and conjugation of fatty acids. , 1974, The Journal of clinical investigation.

[3]  T. Chiba,et al.  Cellular localization of mRNAs for prostaglandin E receptor subtypes in mouse gastrointestinal tract. , 1997, The American journal of physiology.

[4]  S. Narumiya,et al.  Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.

[5]  P. Darney,et al.  Misoprostol and pregnancy. , 2001, The New England journal of medicine.

[6]  R. Breyer,et al.  Prostanoid receptors: subtypes and signaling. , 2001, Annual review of pharmacology and toxicology.

[7]  A. Friebe,et al.  Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase , 2007, Proceedings of the National Academy of Sciences.

[8]  Y. Terada,et al.  On the mechanism of diarrhea due to castor oil. , 1962, Japanese journal of pharmacology.

[9]  S. Narumiya,et al.  Prostaglandin E Receptors* , 2007, Journal of Biological Chemistry.

[10]  M. Simon,et al.  G alpha 15 and G alpha 16 couple a wide variety of receptors to phospholipase C. , 1995, The Journal of biological chemistry.

[11]  S. Tunaru,et al.  Characterization of Determinants of Ligand Binding to the Nicotinic Acid Receptor GPR109A (HM74A/PUMA-G) , 2005, Molecular Pharmacology.

[12]  T. Gaginella,et al.  Ricinoleic acid: Current view of an ancient oil , 1975, The American Journal of Digestive Diseases.

[13]  P. Fossier,et al.  Chimeric green fluorescent protein-aequorin as bioluminescent Ca2+ reporters at the single-cell level. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  W. Watson,et al.  Studies on the digestion, absorption and metabolism of castor oil. , 1962, Biochemical pharmacology.

[15]  Stephen J Lye,et al.  Expression, localization and function of prostaglandin receptors in myometrium. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[16]  S. Narumiya,et al.  Characterization of prostanoid receptors mediating contraction of the gastric fundus and ileum: studies using mice deficient in prostanoid receptors , 2000, British journal of pharmacology.

[17]  L. Wheeler,et al.  The Prevention of Colitis by E Prostanoid Receptor 4 Agonist through Enhancement of Epithelium Survival and Regeneration , 2007, Journal of Pharmacology and Experimental Therapeutics.

[18]  S. Narumiya,et al.  Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. , 1998, Biochemical and biophysical research communications.

[19]  I. Carabin,et al.  Toxicology and pharmacology of sodium ricinoleate. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[20]  C. Saper,et al.  EP3 prostaglandin receptors in the median preoptic nucleus are critical for fever responses , 2007, Nature Neuroscience.

[21]  M. Simon,et al.  Gα15 and Gα16 Couple a Wide Variety of Receptors to Phospholipase C (*) , 1995, The Journal of Biological Chemistry.

[22]  J F Nunn,et al.  Ancient Egyptian medicine. , 1996, Transactions of the Medical Society of London.

[23]  S. Phillips,et al.  Effects of oleic and ricinoleic acids on net jejunal water and electrolyte movement. Perfusion studies in man. , 1974, The Journal of clinical investigation.

[24]  D. Garry,et al.  Use of castor oil in pregnancies at term. , 2000, Alternative therapies in health and medicine.

[25]  S. Narumiya,et al.  Multiple signal transduction pathways through two prostaglandin E receptor EP3 subtype isoforms expressed in human uterus. , 2000, The Journal of clinical endocrinology and metabolism.

[26]  S. Narumiya,et al.  International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress , 2011, Pharmacological Reviews.

[27]  J. Clayton,et al.  In vitro characterization of prostanoid receptors on human myometrium at term pregnancy , 1993, British journal of pharmacology.

[28]  P. Bass,et al.  The effects of sodium ricinoleate on small intestinal function and structure. , 1976, The Journal of clinical investigation.

[29]  H. Binder,et al.  Stimulation of colonic secretion of water and electrolytes by hydroxy fatty acids. , 1973, Gastroenterology.

[30]  Y. Sugimoto,et al.  Two isoforms of prostaglandin E receptor EP3 subtype. Different COOH-terminal domains determine sensitivity to agonist-induced desensitization. , 1993, The Journal of biological chemistry.

[31]  A. Izzo,et al.  Inhibitors of nitric oxide synthase enhance rat ileum contractions induced by ricinoleic acid in vitro. , 1993, European journal of pharmacology.

[32]  P. Bass,et al.  Actions of ricinoleic acid and structurally related fatty acids of the gastrointestinal tract. I. Effects on smooth muscle contractility in vitro. , 1975, Journal of Pharmacology and Experimental Therapeutics.

[33]  M. Lejeune,et al.  Prostaglandin E2 receptor distribution and function in the gastrointestinal tract , 2006, British journal of pharmacology.

[34]  Atsushi Ichikawa,et al.  Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3 , 1998, Nature.

[35]  V. Go,et al.  Cytotoxicity of ricinoleic acid (castor oil) and other intestinal secretagogues on isolated intestinal epithelial cells. , 1977, Journal of Pharmacology and Experimental Therapeutics.

[36]  P. Holzer,et al.  Differential peristaltic motor effects of prostanoid (DP, EP, IP, TP) and leukotriene receptor agonists in the guinea‐pig isolated small intestine , 2002, British journal of pharmacology.

[37]  G. FitzGerald,et al.  Genetic and pharmacological analysis of prostanoid receptor function. , 2001, The Journal of clinical investigation.

[38]  S. Narumiya,et al.  The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. , 2002, The Journal of clinical investigation.

[39]  A. Scarpa,et al.  Various uses of the castor oil plant (Ricinus communis L.). A review. , 1982, Journal of ethnopharmacology.

[40]  L. Saalmüller Ueber die fetten Säuren des Ricinusöls , 1848 .

[41]  J. Mathias,et al.  Ricinoleic acid effect on the electrical activity of the small intestine in rabbits. , 1978, The Journal of clinical investigation.

[42]  F. Alt,et al.  Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[43]  D. Gumucio,et al.  cis Elements of the Villin Gene Control Expression in Restricted Domains of the Vertical (Crypt) and Horizontal (Duodenum, Cecum) Axes of the Intestine* , 2002, The Journal of Biological Chemistry.

[44]  L. Racusen,et al.  Ricinoleic acid stimulation of active anion secretion in colonic mucosa of the rat. , 1979, The Journal of clinical investigation.

[45]  F. Capasso,et al.  Eicosanoid formation by mammalian intestine. Effects of some intestinal secretagogues. , 1987, European journal of pharmacology.